Skip to main content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: memo - Magazine of European Medical Oncology 3/2017

21.08.2017 | comment

Highlights from the 2017 St. Gallen Breast Cancer Consensus

verfasst von: MD Prof. Dr. Georg Pfeiler, Prof. Dr. Rupert Bartsch, MBA F.E.B.S. Univ. Prof. Dr. Florian Fitzal

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten
share
TEILEN

Excerpt

Three topics on endocrine therapy of pre- and postmenopausal patients with hormone-receptor positive breast cancer were discussed in detail: ovarian function suppression (OFS), aromoatase inhibitors (AI) and extended endocrine therapy. The panel acknowledged that patients below 35 years of age, premenopausal after chemotherapy or with 4 or more involved lymph nodes should receive OFS. …
Metadaten
Titel
Highlights from the 2017 St. Gallen Breast Cancer Consensus
verfasst von
MD Prof. Dr. Georg Pfeiler
Prof. Dr. Rupert Bartsch
MBA F.E.B.S. Univ. Prof. Dr. Florian Fitzal
Publikationsdatum
21.08.2017
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 3/2017
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-017-0349-x

Weitere Artikel der Ausgabe 3/2017

memo - Magazine of European Medical Oncology 3/2017 Zur Ausgabe